1,527
Views
1
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Case Report

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report

, , , , , & show all
Article: 2121122 | Received 16 Jul 2022, Accepted 23 Aug 2022, Published online: 26 Sep 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.